Adgyl Lifesciences offers full range of Safety Assessment Services under GLP & Non-GLP for exploratory, IND & NDA stages. We offer Non-GMP & cGMP synthesis services for early and late clinical development.

With over 30+ years of experience conducting safety assessment studies, Adgyl offers a full range of in vivo GLP and non-GLP preclinical studies in multiple species to thoroughly assess the safety profile of your molecules. As an extension of your team, our scientists and technicians help you expedite your research goals, ensuring that your preclinical drug development program provides quality data for key decision making.

We have successfully submitted 90+ IND packages to regulatory agencies across the world – including USFDA, MHRA and EMA. Adgyl is a GLP and AAALAC accredited lab and was successfully audited by the USFDA (2012 and 2016) for GLP studies submitted as part of IND / NDA packages.